KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Gross Profit (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Gross Profit for 16 consecutive years, with -$7.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit fell 155.04% to -$7.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.1 million, a 3.96% decrease, with the full-year FY2025 number at $62.1 million, up 24.0% from a year prior.
  • Gross Profit was -$7.5 million for Q4 2025 at Biolife Solutions, down from $25.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $35.5 million in Q3 2022 to a low of -$37.3 million in Q4 2022.
  • A 5-year average of $16.9 million and a median of $20.0 million in 2023 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: surged 228.06% in 2021, then plummeted 214.77% in 2022.
  • Biolife Solutions' Gross Profit stood at $32.5 million in 2021, then tumbled by 214.77% to -$37.3 million in 2022, then soared by 31.7% to -$25.5 million in 2023, then soared by 153.11% to $13.5 million in 2024, then plummeted by 155.04% to -$7.5 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Gross Profit are -$7.5 million (Q4 2025), $25.5 million (Q3 2025), and $22.7 million (Q2 2025).